Slatkin Symposium



Registration is free for all participants!

Upon completion of the symposium participants will be able to:

  1. Discuss the repercussion of health disparities related to Covid-19 patient outcomes.
  2. List the cardiovascular and metabolic diseases that negatively impact patient recovery from Covid-19 illness.
  3. Explain the procedures implemented by the pharmacy department in response to the Covid-19 pandemic.
    This program is targeted to pharmacists and is sponsored by the Chicago State University College of Pharmacy. The Chicago State University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
    This knowledge-based CPE activity program is equivalent to 2.0 contact hours or 0.2 CEU, ACPE UAN: 0857-0000-20-014-L04-P; 0857-0000-20-014-H04-P
    To earn continuing pharmacy education credit, the attendee must be registered for the meeting via Go To Webinar with correct NABP ID Number and DOB, participate in the entire session, complete and submit self-assessment questions at the end of activity, complete and submit the electronic Speaker Evaluation Survey via Qualtrics at the conclusion of the educational session. Attendees must have their NABP e-profile ID # to receive CPE credit. Allow approximately 4-6 weeks following the program for credits to appear on the NABP e-profile.




5:45 – 6:00 PM

Dr. Matthew Fete, Ph.D, Dean College of Pharmacy

Dr. Jeremy Hughes, PharmD, Associate Dean of Academic Affairs


6:00–6:15 PM

John Cardellina, II, PhD President of the American Society of Pharmacognosy Foundation


Dr. John Cardellina, II, PhD, ASP

Dr. Melany P. Puglisi, PhD, Director of Learning Outcomes


6:15  7:00 PM

"COVID-19 among Underserved and Vulnerable populations: Evidence, Research Needs and Next Steps"  

Monica Webb Hooper, Ph.D.

7:00 – 7:30 PM

"Cues to Factors Linking Metabolic Comorbidities with Covid-19"

Mohd Shahid, PharmB, PharmM, PhD

 7:30 – 8:00 PM

"When Experts Become Learners: Experiences as an Infectious Disease Pharmacist During a Novel Pandemic"

Christy Varughese, PharmD, BCPS


8:00 PM

"Delivery of Equpenifeldin via Polymer-Coated Surgical Buttresses to Prevent Local Lung Cancer Recurrence"

Zeinab Al Subeh

8:07 PM

"IEX-1 is Required for Vitamin D-induced Inhibition of Proinflammatory State of Macrophages"

Faaeiza Khan

8:14 PM

“LC-MSn Based Metabolic Profiling of Cyclopenta[b]benzofurans in Selected Aglaia species Collected from Laos”

Garima Agarwal

8:21 PM

“Endothelial IRF4 Instructs Cytoplasmic SPHK1 to Generate S1P and Resolves Sepsis Induced Inflammatory Injury”

Shamsideen Ali, Do Doan, Malek Hassan and Sandeep Arora

8:28 PM

 “Bioassay-Guided Isolation of Cytotoxic Metabolites from Penicillium aurantiacobrunneum”

Charmaine Lindsay, PhD

8:35 PM

 “Identification of Ligands that Target PBP3 by High Throughput Virtual Screening

Clarreesa Hardin and Amarachukwu Akujieze”

8:42 PM

“Chemical Signals from Caulerpa spp., A Model System for Understanding Quorum Sensing in Vibrio spp.”

Marina Ghazar and Mary Kollo

8:49 PM

“Modulating Effects of Polyherbal Combination on Cyclophosphamide-induced Immunosuppressed Mice”

Abida Parveen, PhD

8:56 PM

“Using Practice Tests to Improve Student Learning Outcomes”

Seifu Teklemariam and Jamal Yusuf

Awards and Closing Remarks

9:00 – 9:15 PM

Use the link below to register for the 2020 David J. Slatkin Memorial Symposium


See Poster Submissions





Donate In lieu of a registration fee for this year’s symposium, the organizers request that participants consider making a donation that will help to change a student’s life.  A student scholarship fund for the Chicago State University College of Pharmacy has been created in the name of the Emeritus Founding Dean David J. Slatkin.  


SlatkinDr. David J. Slatkin

Founding  and Emeritus Dean

Chicago State University College of Pharmacy

Dr. David J. Slatkin was one of the country’s most influential pharmacists and has made tremendous contributions to the field of pharmaceutical sciences, pharmacognosy and pharmaceutical education. His distinguished career as a teacher and administrator included service at Northeast Louisiana University School of Pharmacy, University of Pittsburgh School of Pharmacy, and the Midwestern University College of Pharmacy, Glendale.

He was the founding dean of three colleges of pharmacy, including the Chicago State University College of Pharmacy. For more information about David Slatkin.  His distinguished career included founding three colleges of pharmacy, multiple faculty positions, and pharmacognosy research. He was awarded the Merck Award from Mercer University, the American Foundation for Pharmaceutical Education, Edwin Leigh Newcomb Memorial Fellow at the University of Mississippi, and was selected by American Pharmacist magazine in 1999 as one of the 50 Most Influential Pharmacists in the country. An author of more than 80 scientific publications, he served as reviewer for the Journal of Natural Products and the Journal of Pharmaceutical Sciences. He has served as treasurer of the American Society of Pharmacognosy for over 30 years and is a member of the Rho Chi Honorary Society and the Phi Delta Chi pharmacy fraternity.

Dr. Slatkin held bachelor’s degrees from Wayne State University, Detroit, and Mercer University’s Southern School of Pharmacy, Atlanta; a master’s degree and Ph. D. from the University of Mississippi School Of Pharmacy.



Sponsored by: 


Students and postdocs are invited to participate in a one hour virtual poster competition for the Slatkin Symposium featuring the pharmaceutical and clinical sciences. 




Monica WebbDr. Monica Webb Hooper

Deputy Director of the National Institute on Minority Health and Health Disparities (NIMHD)

National Institutes of Health

Dr. Monica Webb Hooperis Deputy Director of the National Institute on Minority Health and Health Disparities (NIMHD). She works closely with the Director, Dr. Pérez-Stable, and the leadership, to oversee all aspects of the institute and to support the implementation of the science visioning recommendations to improve minority health, reduce health disparities, and promote health equity.   

Dr. Webb Hooper is an internationally recognized translational behavioral scientist and clinical health psychologist. She has dedicated her career to the scientific study of minority health and racial/ethnic disparities, focusing on chronic illness prevention and health behavior change. Her program of community engaged research focuses on understanding multilevel factors and biopsychosocial mechanisms underlying modifiable risk factors, such as tobacco use and stress processes, and the development of community responsive and culturally specific interventions. Her goal is to contribute to the body of scientific knowledge and disseminate findings into communities with high need.

Before joining NIMHD, Dr. Webb Hooper was a Professor of Oncology, Family Medicine & Community Health and Psychological Sciences at Case Western Reserve University. She was also Associate Director for Cancer Disparities Research and Director of the Office of Cancer Disparities Research in the Case Comprehensive Cancer Center. During her time as a professor, Dr. Webb Hooper was principal investigator of federal and foundation grants, totaling over $15 million. To date, she has published over 90 peer-reviewed articles and book chapters.

Dr. Webb Hooper completed her doctorate in clinical psychology from the University of South Florida, internship in medical psychology from the University of Florida Health Sciences Center, and her Bachelor of Science from the University of Miami.


Mohd ShadidDr. Mohd Shahid

Assistant Professor, Department of Pharmaceutical Sciences

Chicago State University College of Pharmacy

Dr. Mohd Shahid, PharmBS, PharmMS, PhD, FPGEC is a pharmacologist/cardiovascular physiologist and an Assistant Professor of Pharmacology at the Chicago State University College of Pharmacy (CSU-COP). He earned his Ph.D., in cardiovascular pharmacology from the Faculty of Medical Sciences at University of Delhi. Prior to coming to CSU, Dr. Shahid was an Instructor and Assistant in Pharmacology at the Massachusetts General Hospital, Harvard Medical School in Boston, where he completed a post-doctoral fellowship in cardiovascular and metabolic disorders in 2012. In 2015 at Massachusetts General Previously, he completed a predoctoral fellowship in renal hypertension at Tulane University in New Orleans. Dr. Shahid’s research interests consist of understanding the role of immune cells especially macrophages in the pathogenesis of cardiovascular and metabolic disorders and exploring the translational significance of his findings. The current research in his laboratory at the CSU is focused on investigating the role of macrophage in the development of atherosclerosis, osteoporosis, and obesity. He has published many research papers in the top peer-reviewed journals and received several awards for his scientific contribution from prestigious organizations such as the American Federation of Medical Research (AFMR), the American Heart Association, and the Harvard Medical School. Dr. Shahid’s research activities have been supported by the funding from National Institute of Health (NIH), AHA, Harvard University, and Chicago State University. He is also a visiting faculty at the Massachusetts General Hospital in Boston. He has been invited as a guest speaker by many reputed institutes including MGH, Rush University, California Northstate University, and Hamdard University.

He was recently awarded the prestigious American Heart Association (AHA) AIREA grant and National Institute of Health (NIH) of the USA SC3 grant for a total amount of approximately half a million dollars. These awards were bestowed upon him to conduct research to investigate for novel drug targets for the treatment and diagnosis of atherosclerosis and coronary heart diseases-The major cause of heart attack and stroke in the world. Atherosclerosis is a disease of the blood vessels (arteries) characterized by the deposition of plaques of fatty material on their inner walls, blocking the blood supply to the heart and brain. In March 2020, he was invited by the American Association of Immunologist (AAI) to present his research work at their annual meeting in Hawaii, Honolulu, in the USA. He was also awarded AAI Early Career Faculty Travel Award to attend the conference. Considering his important scientific contributions, the Chicago State University awarded him with the Faculty Excellence Award in Research  for two consecutive years in 2019 and 2020.


Christy VarugheseDr. Christy Varughese

Clinical Pharmacist, Infectious Disease

Rush University Medical Center

Christy Varughese, PharmD is an infectious disease clinical pharmacy specialist at Rush University Medical Center in Chicago, IL. She and her ID pharmacist colleague Hayley Hodgson lead the antimicrobial stewardship program at RUMC, with the primary goal of improving patient safety, judicious use of antimicrobials, and slowing the spread of multidrug resistant organisms.  She works closely with the infectious disease service to manage difficult to treat infections and developing infectious disease guidelines for hospital wide use. She is also a preceptor and mentor to   pharmacy residents and students.

Before joining RUMC, Dr. Varughese was the pharmacy clinical lead for Infectious Disease at Massachusetts General Hospital in Boston, MA. During her time in Boston, she developed an antimicrobial stewardship program and co-led with medical director Alyssa Letourneau, MD.

Dr. Varughese completed her doctorate in pharmacy from Massachusetts College of Pharmacy in Boston; PGY1 residency at Rush University Medical Center; PGY2 in Infectious Disease at Yale-New Haven Hospital. She completed her Masters in Clinical Research at Rush University. To date, she has published over 20 peer-reviewed articles and book chapters. Her primary research interests are in antimicrobial stewardship, opportunistic infections, and multidrug resistant organisms.


John Cardellina

John Cardellina, II, PhD  
Dr. Cardellina received his PhD from the University of Hawaii under the direction of Dr. Richard E. Moore, a pioneer in cyanobacterial natural products.  He has over 50 years of diverse experience providing effective program design, development, management and leadership in the US Navy, academia, government, pharmaceutical and flavor/herb/spice industry R&D, and private sector trade association representing the dietary supplement industry.  His research interests include natural products, organic, medicinal, and analytical chemistry.  A thirty eight year member of this scientific society, have served on numerous committees, culminating in election to presidency (2000-2001); currently chair of ASP Foundation Board, and co-chaired two annual meeting organizing committees and an interim meeting on commercial botanicals. Selected as an Honorary Member and Fellow of the ASP.

FACULTY DISCLOSURE: It is the policy of the Chicago State University College of Pharmacy to ensure balance, independence, objectivity, and scientific rigor in all of its education programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of these continuing pharmacy education programs. The speakers and organizing committee have no conflicts to disclose.


Chair, Melany P. Puglisi-Weening, PhD., Professor of Pharmaceutical Sciences & Director of Learning Outcomes

Naomi Simwenyi, Director of Continuing Education

Edward Ofori, Ph.D., Assistant Professor of Pharmaceutical Sciences

Jeremy Hughes, PharmD, EdD.c., Associate Dean for Academic Affairs and Associate Professor